

Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1006 | 1006 | 943 | 1068 | 1497 | 1858 |
Fund Return | 0.63% | 0.63% | -5.71% | 2.2% | 8.41% | 6.39% |
Place in category | 80 | 80 | 95 | 64 | 79 | 49 |
% in Category | 42 | 42 | 56 | 35 | 52 | 45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 730.53B | -4.82 | 8.12 | - | ||
Vanguard 500 Index Admiral | 568.34B | -4.28 | 9.02 | 12.46 | ||
Vanguard Total Stock Market Admiral | 407.95B | -4.83 | 8.10 | 11.74 | ||
Vanguard Total Intl Stock Index Inv | 209.79B | 5.46 | 4.59 | 5.14 | ||
Vanguard 500 Index Institutional Se | 207.17B | -4.28 | 9.05 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Health Sciences | 6.8B | -0.04 | 0.26 | 7.27 | ||
Fidelity Select Health Care | 6.42B | -1.03 | 1.10 | 6.91 | ||
Vanguard Health Care Inv | 6.25B | 0.62 | 2.15 | 6.34 | ||
T. Rowe Price Health Sciences I | 4.79B | 0.00 | 0.39 | - | ||
Fidelity Select Medical Equip & Sy | 4.63B | -2.25 | -2.34 | 10.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.69 | 757.23 | +0.38% | |
UnitedHealth | US91324P1021 | 7.83 | 583.41 | -0.62% | |
AstraZeneca | GB0009895292 | 5.73 | 10,280.0 | -0.39% | |
Merck&Co | US58933Y1055 | 5.28 | 78.14 | -1.30% | |
Novo Nordisk B | DK0062498333 | 4.49 | 425.7 | -2.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review